Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapy.
Pieters RC, Vermorken JB, Gall HE, Nauta JJ, van Loenen AC, van Groeningen CJ, van Rijswijk RE, Brenninkmeijer JH, Pinedo HM. Pieters RC, et al. Among authors: gall he. Oncology. 1993 Jul-Aug;50(4):316-22. doi: 10.1159/000227202. Oncology. 1993. PMID: 8497383 Clinical Trial.
Pharmacokinetics of S-1, an oral formulation of ftorafur, oxonic acid and 5-chloro-2,4-dihydroxypyridine (molar ratio 1:0.4:1) in patients with solid tumors.
Peters GJ, Noordhuis P, Van Kuilenburg AB, Schornagel JH, Gall H, Turner SL, Swart MS, Voorn D, Van Gennip AH, Wanders J, Holwerda U, Smid K, Giaccone G, Fumoleau P, Van Groeningen CJ. Peters GJ, et al. Among authors: gall h. Cancer Chemother Pharmacol. 2003 Jul;52(1):1-12. doi: 10.1007/s00280-003-0617-9. Epub 2003 May 9. Cancer Chemother Pharmacol. 2003. PMID: 12739060 Clinical Trial.
Pharmacokinetics of free and total platinum species after rapid and prolonged infusions of aqua (1,1-bis(aminomethyl)cyclohexane) sulfatoplatinum (II) (spiroplatin) during a phase I trial.
van der Vijgh WJ, Elferink F, Vermorken JB, ten Bokkel Huinink WW, Klein I, Gall HE, Simonetti G, McVie JG, Pinedo HM. van der Vijgh WJ, et al. Among authors: gall he. Eur J Cancer Clin Oncol. 1988 Apr;24(4):621-7. doi: 10.1016/0277-5379(88)90290-8. Eur J Cancer Clin Oncol. 1988. PMID: 3383966
Phase I study of spiroplatin.
Tanis BC, Vermorken JB, ten Bokkel Huinink WW, Klein I, Gall H, van Oosterom AT, Simonetti G, McVie JG, van der Vijgh WJ, Pinedo HM. Tanis BC, et al. Among authors: gall h. Eur J Cancer. 1991;27(3):268-73. doi: 10.1016/0277-5379(91)90513-d. Eur J Cancer. 1991. PMID: 1827311 Clinical Trial.
406 results